VKTX |
Viking Therapeutics, Inc. |
Oct 28, 2024 |
16 |
-$9.38M |
4 |
Oct 28, 2024 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Jul 29, 2024 |
5 |
-$922K |
4 |
Jul 31, 2024 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
May 3, 2024 |
8 |
-$4.82M |
4 |
May 3, 2024 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Mar 27, 2024 |
2 |
-$1.38M |
4 |
Mar 27, 2024 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Mar 1, 2024 |
2 |
-$1.71M |
4 |
Mar 4, 2024 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Jan 3, 2024 |
7 |
-$1.38M |
4 |
Jan 4, 2024 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Apr 17, 2023 |
3 |
-$52K |
4 |
Apr 18, 2023 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Apr 11, 2023 |
14 |
-$1.22M |
4 |
Apr 13, 2023 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Mar 30, 2023 |
14 |
-$2.83M |
4 |
Apr 3, 2023 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Dec 30, 2022 |
6 |
-$563K |
4 |
Jan 4, 2023 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Jan 3, 2022 |
4 |
-$55.9K |
4 |
Jan 5, 2022 |
Chief Financial Officer |
VKTX |
Viking Therapeutics, Inc. |
Sep 28, 2021 |
2 |
-$15K |
4 |
Sep 30, 2021 |
Chief Financial Officer |